Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Longo
Raffaele
R
Division of Medical Oncology, San Filippo Neri Hospital, Rome, Italy.
Castellana
Maria Angela
MA
Gasparini
Giampietro
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D003475:Curettage; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D050278:Finger Phalanges / Q000000981:diagnostic imaging / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007571:Jaw Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000628:therapy; D010027:Osteotomy; D011859:Radiography; D013933:Thumb; D000077211:Zoledronic Acid
D000900:Anti-Bacterial Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid